|
|
(2 intermediate revisions not shown.) |
Line 3: |
Line 3: |
| <StructureSection load='1afq' size='340' side='right'caption='[[1afq]], [[Resolution|resolution]] 1.80Å' scene=''> | | <StructureSection load='1afq' size='340' side='right'caption='[[1afq]], [[Resolution|resolution]] 1.80Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[1afq]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AFQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1AFQ FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[1afq]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AFQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1AFQ FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0FG:D-LEUCYL-N-(4-FLUOROBENZYL)-L-PHENYLALANINAMIDE'>0FG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.8Å</td></tr> |
- | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Chymotrypsin Chymotrypsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.1 3.4.21.1] </span></td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0FG:D-LEUCYL-N-(4-FLUOROBENZYL)-L-PHENYLALANINAMIDE'>0FG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1afq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1afq OCA], [http://pdbe.org/1afq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1afq RCSB], [http://www.ebi.ac.uk/pdbsum/1afq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=1afq ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1afq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1afq OCA], [https://pdbe.org/1afq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1afq RCSB], [https://www.ebi.ac.uk/pdbsum/1afq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1afq ProSAT]</span></td></tr> |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/CTRA_BOVIN CTRA_BOVIN] |
| == Evolutionary Conservation == | | == Evolutionary Conservation == |
| [[Image:Consurf_key_small.gif|200px|right]] | | [[Image:Consurf_key_small.gif|200px|right]] |
Line 13: |
Line 15: |
| <jmolCheckbox> | | <jmolCheckbox> |
| <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/af/1afq_consurf.spt"</scriptWhenChecked> | | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/af/1afq_consurf.spt"</scriptWhenChecked> |
- | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | + | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked> |
| <text>to colour the structure by Evolutionary Conservation</text> | | <text>to colour the structure by Evolutionary Conservation</text> |
| </jmolCheckbox> | | </jmolCheckbox> |
Line 30: |
Line 32: |
| ==See Also== | | ==See Also== |
| *[[Chymotrypsin 3D structures|Chymotrypsin 3D structures]] | | *[[Chymotrypsin 3D structures|Chymotrypsin 3D structures]] |
- | *[[User:Michael Roberts/BIOL115 Chymo|User:Michael Roberts/BIOL115 Chymo]] | |
| == References == | | == References == |
| <references/> | | <references/> |
Line 36: |
Line 37: |
| </StructureSection> | | </StructureSection> |
| [[Category: Bos taurus]] | | [[Category: Bos taurus]] |
- | [[Category: Chymotrypsin]] | |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Inoue, Y]] | + | [[Category: Inoue Y]] |
- | [[Category: Kashima, A]] | + | [[Category: Kashima A]] |
- | [[Category: Maeda, I]] | + | [[Category: Maeda I]] |
- | [[Category: Nose, T]] | + | [[Category: Nose T]] |
- | [[Category: Shimohigashi, Y]] | + | [[Category: Shimohigashi Y]] |
- | [[Category: Sugio, S]] | + | [[Category: Sugio S]] |
- | [[Category: Hydrolase-hydrolase inhibitor complex]]
| + | |
| Structural highlights
Function
CTRA_BOVIN
Evolutionary Conservation
Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf.
Publication Abstract from PubMed
The dipeptide D-leucyl-L-phenylalanyl p-fluorobenzylamide (D-Leu-Phe-NH-BzlF) inhibits chymotrypsin strongly in a competitive manner with the Ki value of 0.61 microM [Shimohigashi, Y., Maeda, I., Nose, T., Ikesue, K., Sakamoto, H., Ogawa, T., Ide, Y., Kawahara, M., Nezu, T., Terada, Y., Kawano, K. & Ohno, M. (1996) J. Chem. Soc. Perkin Trans. 1, 2479-2485]. The structure/activity studies have suggested a unique inhibitory conformation, in which the C-terminal benzyl group fits the chymotrypsin S1 site and the hydrophobic core constructed by the side chains of D-Leu-Phe fits the S2 or S1' site. To verify this assumption, the molecular structure of the complex between the dipeptide and gamma-chymotrypsin has been determined crystallographically. Gamma-chymotrypsin itself was first crystallized and refined at 1.6-A resolution. The refined structure was virtually identical to the conformation reported and the electron density at the active site was interpreted as a pentapeptide Thr-Pro-Gly-Val-Tyr derived from autolysis of the enzyme (residues 224-228). The chymotrypsin-dipeptide complex was obtained by soaking the crystals of gamma-chymotrypsin in a solution saturated with the dipeptide inhibitor. The crystal structure of the complex has been refined at 1.8-A resolution to a crystallographic R-factor of 18.1%. The structure of gamma-chymotrypsin in the complex agreed fairly well with that of gamma-chymotrypsin per se with a rmsd of 0.13 A for all the C alpha carbons. Two inhibitor molecules were assigned in an asymmetric unit, i.e. one in the active site and the other at the interface of two symmetry-related enzyme molecules. In both sites dipeptides adopted very similar folded conformations, in which side chains of D-Leu-Phe are spatially proximal. In the active site where the binding of dipeptide was judged to be a direct cause of inhibition, C-terminal p-fluorobenzylamide group of the dipeptide, NH-BzlF, was found in the S1 hydrophobic pocket. At the bottom of this pocket, the p-fluorine atom hydrogen bonded with a water molecule, probably to enhance the inhibitory activity. The stereospecific interaction of R and S isomers of the dipeptide with C-terminal NH-C*H(CH3)-C6H5 was well explained by the space available for methyl replacement in the complex. The hydrophobic core constructed by side chains of D-Leu-Phe was found at the broad S2 site. Interestingly, a novel interaction was found between the inhibitor Phe residue and chymotrypsin His57, the phenyl of Phe and the imidazole of His being in a pi-pi stacking interaction at a distance 3.75 A.
X-ray crystal structure of a dipeptide-chymotrypsin complex in an inhibitory interaction.,Kashima A, Inoue Y, Sugio S, Maeda I, Nose T, Shimohigashi Y Eur J Biochem. 1998 Jul 1;255(1):12-23. PMID:9692896[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Kashima A, Inoue Y, Sugio S, Maeda I, Nose T, Shimohigashi Y. X-ray crystal structure of a dipeptide-chymotrypsin complex in an inhibitory interaction. Eur J Biochem. 1998 Jul 1;255(1):12-23. PMID:9692896
|